
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145764510.1021/acsomega.7b00383ArticleSynthesis of 3-CF2-Containing
Chromones via a Visible-Light-Induced Radical Cascade Reaction of o-Hydroxyaryl Enaminones Gao Huang †Hu Bei †Dong Wuheng †Gao Xiaoshuang †Jiang Lili †Xie Xiaomin †Zhang Zhaoguo *†‡† School
of Chemistry and Chemical Engineering, Shanghai
Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China‡ Shanghai
Institute of Organic Chemistry, Chinese
Academy of Sciences, 345 Lingling Road, Shanghai 200032, China* E-mail: zhaoguo@sjtu.edu.cn. Phone/Fax: (+86)-21-5474-8925.05 07 2017 31 07 2017 2 7 3168 3174 30 03 2017 14 06 2017 Copyright © 2017 American Chemical Society2017American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A general and efficient
visible-light-induced CF2 radical-based
cascade reaction of o-hydroxyaryl enaminones has
been described. This protocol afforded the corresponding functionalized
3-CF2-containing chromones in generally good yields under
mild reaction conditions. The use of NaHSO3, which has
both basicity and reducibility, efficiently suppressed the formation
of two byproducts, 4H-chromen-4-one and 3-bromo-4H-chromen-4-one.

document-id-old-9ao7b00383document-id-new-14ao-2017-00383dccc-price
==== Body
Introduction
Owing to their unique
biological, physical, and chemical properties,
fluoroalkylated organic substances are of great importance in a variety
of disciplines.1 Among these compounds,
molecules containing a difluoromethyl group (RCF2−)
are especially desirable building blocks for use in medicinal chemistry
because of their superior lipophilicity, binding selectivity, and
metabolic stability. Several efficient methods for introducing the
difluoromethyl unit into organic molecules have been reported:2 one of these methods involves the use of a metal
difluorinating reagent, including copper,3 silver,4 tin reagents,5 and so on. Difluoromethyl carboxylic acid skeletons (CF2CONR1R2, CF2CO2Et, and CF2PO(OEt)2), which serve as another
source of the difluoromethyl group, have attracted considerable attention
because they are readily available and can be easily transformed into
other fluorine-containing groups.6

Chromones are important moieties found in natural products and
pharmaceuticals;7 a number of approaches
for the synthesis of their derivatives, especially for the synthesis
of C3-functionalized analogues from o-hydroxyl-acetophenones
by the tandem cyclization process, have been developed. These syntheses
are characterized
by the Baker–Venkataraman reaction, Claisen–Schmidt
reaction, and Vilsmeier–Haack reaction, and so on.7b Given their importance, the development of a
new, efficient method for the synthesis of 3-CF2-incorporated
chromone derivatives is still in demand. In 2013, Yang’s group
reported the first synthesis of 3-CF2-containing chromones
via palladium-catalyzed cross-coupling of ethyl bromodifluoroacetate
with 3-iodochromones (Scheme 1, method A),8a and very recently,
Yang and Chen reported a visible-light-driven, radical-triggered tandem
cyclization of o-hydroxyaryl enaminones (Scheme 1, method B).8b However, the yield of the product under the
oxidation cycle of iridium is not ideal. The synthesis of 3-CF2-containing chromones via a ruthenium reduction cycle may
be a cheaper and an efficient method.

Scheme 1 Synthesis of 3-CF2-Containing Chromones
Photoredox catalysis provides a green and sustainable
synthetic
method for the assembly of diverse important compounds under mild
reaction conditions.9 In the extensively
explored synthesis of fluorinated molecules, a variety of fluorinating
reagents, including BrCF2CO2R, have been used
to generate CF2 radicals under visible light.10 Herein, we report an efficient synthesis of
3-CF2-containing chromones via the photocatalytic radical
cascade reaction of o-hydroxyaryl enaminones with
ethyl bromodifluoroacetate in one step (Scheme 1, method C).

Results and Discussion
We have reported a ruthenium-catalyzed reaction of α-bromocarboxylates
and enamines to generate γ-ketoesters under visible light. In
this reaction, Et3N was used to reduce [Ru(bpy)3]2+* to [Ru(bpy)3]+; then, [Ru(bpy)3]+ underwent
a single-electron transfer process with the C–Br bond of ethyl
bromodifluoroacetate to generate an electron-deficient radical to
react with enamines.11 We initiated our
study with (E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one
(1a) and ethyl bromodifluoroacetate, with Ru(bpy)3Cl2 (1 mol %) as the catalyst and Et3N (40 mol %) as the initial reducing agent under irradiation with
a 45 W LED lamp, intending to develop a cascade radical addition–cyclization
reaction. Fortunately, the reaction did occur at room temperature,
giving the desired 3-CF2-containing chromone, 2a, in 14% yield, along with two byproducts, 4H-chromen-4-one
(3a, 16%) and 3-bromo-4H-chromen-4-one
(4a, 6%) (Table 1, entry 1). The presence of 3a indicated a self-ring-closure
reaction of 1a, and the formation of 4a implied
the electrophilic addition reaction of 3a with Br2, followed by dehydrobromination.12 It is evident that the reaction will produce HBr, which may weaken
the reducibility of Et3N and the nucleophilicity of the
phenolic hydroxyl group of the substrate. To improve the efficiency
of the reaction, we examined the influence of the bases, and the results
are summarized in Table 1.

Table 1 Optimization of the Reaction Conditionsa
 	 	 	 	yieldb (%)	
entry	catalyst	solvent	base	2a	3a	4a	
1	Ru(bpy)3Cl2	dimethyl
sulfoxide (DMSO)	 	14	16	6	
2	Ru(bpy)3Cl2	DMSO	NaOAc	22	25	25	
3	Ru(bpy)3Cl2	DMSO	Na2HPO4	52	33	trace	
4	Ru(bpy)3Cl2	DMSO	NaH2PO4	trace	68	27	
5	Ru(bpy)3Cl2	DMSO	Na2CO3	trace	trace	trace	
6	Ru(bpy)3Cl2	DMSO	Na2SO3	76	 	 	
7	Ru(bpy)3Cl2	DMSO	NaHSO3	81	 	 	
8	Ru(bpy)3Cl2	MeCN	NaHSO3	trace	trace	trace	
9	Ru(bpy)3Cl2	CH3OH	NaHSO3	 	27	 	
10	Ru(bpy)3Cl2	DCE	NaHSO3	trace	trace	trace	
11	rhodamine	DMSO	NaHSO3	trace	 	 	
12	acid
red 87	DMSO	NaHSO3	trace	 	 	
13	rose bengal	DMSO	NaHSO3	74	 	 	
14	fac-Ir(ppy)3	DMSO	NaHSO3	75	 	 	
15c	Ru(bpy)3Cl2	DMSO	NaHSO3	68%	 	 	
16d	Ru(bpy)3Cl2	DMSO	NaHSO3	60%	21%	 	
17e	Ru(bpy)3Cl2	DMSO	NaHSO3	60%	 	 	
18f	none	DMSO	NaHSO3	0	 	 	
19g	Ru(bpy)3Cl2	DMSO	NaHSO3	0	 	 	
a Reaction conditions: 1a (95.61 mg, 0.5 mmol), BrCF2COOEt (253.73 mg, 2.5 equiv),
base (1.5 equiv), Et3N (0.4 equiv), catalyst (1 mol %),
solvent (6 mL), irradiation with a 45 W household light bulb, rt,
24 h.

b Isolated yield.

c Without Et3N.

d BrCF2COOEt (1.5 equiv).

e 18 h.

f Without catalyst.

g Without light.

When NaOAc was used as the base, the reaction gave a better conversion
and a slightly higher yield of the desired product (Table 1, entry 2). When Na2HPO4 was used as the base, the yield was obviously improved
(Table 1, entry 3);
however, when we changed the base to NaH2PO4, an almost quantitative yield of byproducts was observed instead
of the desired product (Table 1, entry 4). There was almost no product or byproduct observed
when the stronger base Na2CO3 was used in the
reaction (Table 1,
entry 5). One can envision that the addition of a reductive base may
reduce the Br2 possibly produced in the reaction and inhibit
the production of byproduct 4a. To our delight, some
bases with a certain degree of reducibility, such as Na2SO3 and NaHSO3, led to a much higher yield
of the desired product, with no detectable byproducts, 3a or 4a (Table 1, entries 6 and 7). Solvent screening proved DMSO to be more
superior to other solvents in the presence of NaHSO3 (Table 1, entries 8–10).
Further optimization of reaction conditions did not improve the yield
of the product when other catalysts were investigated (Table 1, entries 11–14). We
also conducted further study on the quantity of Et3N, which
showed that 40% equiv Et3N was enough to achieve good yields,
but the absence of Et3N resulted in a decrease in yield
(Table 1, entry 15).
When the amount of ethyl bromodifluoroacetate was reduced to 1.5 equiv,
the yield of the desired product was decreased (Table 1, entry 16); when the reaction time was shortened
to 18 h, only 60% of the desired product was obtained, with unreacted
starting material (Table 1, entry 17). Besides this, control experiments showed that
both Ru(bpy)3Cl2 and visible light are essential
for this reaction (Table 1, entries 18 and 19).

With these optimized reaction
conditions in hand, we explored the
substrate scope with different o-hydroxyaryl enaminone
derivatives. We were pleased to find that both the electron-withdrawing
and -donating substituents on the aromatic ring of (E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one were suitable
substrates to obtain the target products in moderate to high yields
(Table 2, 2b–l), and the reaction tolerated various functional
groups, including fluoro, chloro, methyl, methoxyl, and cyano groups.
It was noteworthy that the position of the substituent on the aromatic
ring has a dramatic influence. The substituents at the meta position
of the aromatic ring of (E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one
gave lower yields than those of substituents at the ortho or para
position. Substrates with a methyl, methoxyl, or fluoro group at the
ortho or para position afforded the corresponding 3-CF2-containing chromones in good yields (Table 2; 2b, 2d, 2e, 2g, 2j), whereas substrates
with a methyl, methoxyl, or fluoro group at the meta position gave
only moderate yields (Table 2; 2c, 2f, 2i).

Table 2 Substrate Scope of the Reactiona,b
a Reaction conditions: 1 (0.5 mmol), BrCF2COOEt (2.5 equiv), base (1.5
equiv),
Et3N (0.4 equiv), catalyst (1 mol %), solvent (6 mL), irradiation
with a 45 W LED bulb, rt, 24 h.

b Isolated yield.

To understand
the mechanism of the reaction, two control experiments
were performed (Scheme 2). The results of reaction (1) showed that 4H-chromen-4-one 3a could not be converted to the desired product under our
standard conditions, which means that the target product is not generated
from the addition of chromone 3a with ethyl bromodifluoroacetate.
At the same time, when 4 equiv of TEMPO relative to 1a was added to the reaction system, the target product was not detected,
which indicates that the mechanism of the reaction is likely to be
radical addition.

Scheme 2 Control Experiments
On the basis of the above experiments, we proposed a mechanism
for the formation of the desired 3-CF2-containing chromones
under visible light (Scheme 3). At first, irradiation of the catalyst [Ru(bpy)3]2+ under visible light generated the excited species
[Ru(bpy)3]2+*, which oxidized Et3N to form the new species [Ru(bpy)3]1+. The electron-rich metal complex [Ru(bpy)3]+ then underwent a single-electron transfer process
with the C–Br bond of ethyl bromodifluoroacetate to afford
an electron-deficient radical I and regenerate [Ru(bpy)3]2+. Radical I was added to the α-position
of α, β unsaturated ketone 1a to form radical II. Radical II also participated in the reduction
of [Ru(bpy)3]2+* to generate the iminium cation intermediate III and form the metal complex [Ru(bpy)3]+, with
the completion of the photoredox catalytic cycle. Hydroxyl groups
on benzene rings attacked the iminium cation to give intermediate IV. Finally, the dimethylamine was eliminated to give the
desired product.

Scheme 3 Proposed Mechanism
Conclusions
In summary, we have developed an efficient
method for the generation
of chromone derivatives by the radical addition reaction of (E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one
and ethyl bromodifluoroacetate under visible light. This reaction
allows for the construction of chromone derivatives, which are useful
synthetic intermediates and important skeletons of biologically active
molecules in organic synthesis, with a broad substrate scope, under
mild conditions in good to excellent yields.

Experimental Section
General
Procedures
Chemicals purchased from commercial
sources were used without further purification. Anhydrous DMSO was
freshly distilled from calcium hydride. 1H NMR and 13C NMR spectra were recorded on a 400 MHz spectrometer. The
chemical shifts for 1H NMR were recorded in ppm downfield
from the solvent using CDCl3 (for 1H, δ
= 7.26) resonance as the internal standard. The chemical shifts for 13C NMR were recorded in ppm downfield using the central peak
of deuterochloroform (77.16 ppm) as the internal standard. 19F NMR was recorded at 376 MHz using CF3COOH as an external
standard. The abbreviations of splitting patterns are described as
follows: s = singlet, d = doublet, t = triplet, q = quartet, m= multiplet,
dd = doublet of doublets. HRMS was performed using the ESI ionization
technique on a Q-TOF Mass Spectrometer. Flash column chromatography
was performed on silica gel (300–400 mesh).

Typical Procedure
for the Synthesis of o-Hydroxyaryl
Enaminones (1a–l)13
A solution of 1-(2-hydroxyphenyl)ethanone (1.00 g, 7.34
mmol) and 1,1-dimethoxy-N,N-dimethylmethanamine
(1.31 g, 11.02 mmol) in anhydrous xylene (6 mL) in a 25 mL flask was
heated to reflux for 12 h. After the reaction was completed, the solid
was precipitated by cooling the solution to room temperature and was
then filtered to give the crude product. The crude product was recrystallized
from EtOH to give the desired substrate.

(E)-3-(Dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one
(1a)14
Yellow solid,
1.20 g, 80% yield. Mp: 130.4–131.0 °C. 1H NMR
(400 MHz, CDCl3): δ 13.98 (s, 1H), 7.87 (d, J = 12.0 Hz, 1H), 7.69 (dd, J = 8.0, 1.2
Hz, 1H), 7.37–7.32 (m, 1H), 6.93 (dd, J =
8.0, 0.8 Hz, 1H), 6.84–6.79 (m, 1H), 5.77 (d, J = 12.0 Hz, 1H), 3.18 (s, 3H), 2.96 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 191.6, 163.0,
154.9, 134.1, 128.3, 120.4, 118.3, 118.1, 90.1, 45.5, 37.5.

3-(Dimethylamino)-1-(2-fluoro-6-hydroxyphenyl)prop-2-en-1-one
(1b)
Yellow solid, 0.38 g, 64% yield. Mp: 67.4–68.9
°C. 1H NMR (400 MHz, CDCl3): δ 14.45
(s, 1H), 7.99 (dd, J = 12.4, 3.2 Hz, 1H), 7.24–7.20
(m, 1H), 6.70 (d, J = 8.4 Hz, 1H), 6.54–6.48
(m, 1H), 5.92 (d, J = 12.4 Hz, 1H), 3.20 (s, 3H),
2.97 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 188.6 (d, J = 4.6 Hz), 164.7 (d, J = 5.3 Hz), 162.5 (d, J = 250.7 Hz), 155.7,
133.3 (d, J = 12.8 Hz), 114.1 (d, J = 3.1 Hz), 110.6 (d, J = 13.1 Hz), 105.6 (d, J = 25.6 Hz), 96.2 (d, J = 18.8 Hz), 45.7,
37.7. 19F NMR (376 MHz, CDCl3): δ −29.5.
HRMS-ESI (m/z): Calculated for C11H12FNO2 (M + H)+: 210.0930,
Found: 210.0930.

(E)-3-(Dimethylamino)-1-(5-fluoro-2-hydroxyphenyl)prop-2-en-1-one
(1c)14
Brown solid,
1.00 g, 69% yield. Mp: 126.4–127.7 °C. 1H NMR
(400 MHz, CDCl3): δ 13.65 (s, 1H), 7.90 (d, J = 12.4 Hz, 1H), 7.35 (dd, J = 9.6, 3.2
Hz, 1H), 7.10–7.04 (m, 1H), 6.88 (dd, J =
9.2, 4.8 Hz, 1H), 5.65 (d, J = 12.4 Hz, 1H), 3.21
(s, 3H), 2.98 (s, 3H). 13C {1H} NMR (100 MHz,
CDCl3): δ 190.4, 159.1, 154.9 (d, J = 234.4 Hz), 155.3, 121.2 (d, J = 23.2 Hz), 120.2
(d, J = 5.9 Hz), 119.2 (d, J = 7.3
Hz), 113.5 (d, J = 23.0 Hz), 89.9, 45.7, 37.7. 19F NMR (376 MHz, CDCl3): δ −48.1.

(E)-3-(Dimethylamino)-1-(4-fluoro-2-hydroxyphenyl)prop-2-en-1-one
(1d)14
Yellow solid,
1.11 g, 82% yield. Mp: 133.1–134.1 °C. 1H NMR
(400 MHz, CDCl3): δ 14.45 (s, 1H), 7.87 (d, J = 12.0 Hz, 1H), 7.67 (dd, J = 8.8, 6.8
Hz, 1H), 6.60 (dd, J = 10.4, 2.4 Hz, 1H), 6.54–6.48
(m, 1H), 5.66 (d, J = 12.0 Hz, 1H), 3.19 (s, 3H),
2.96 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 190.5, 166.2 (d, J = 250. 9 Hz),
165.5 (d, J = 13.6 Hz), 154.9, 130.3–130.2
(d, J = 11.3 Hz), 117.2 (d, J =
2.5 Hz), 106.0 (d, J = 22.3 Hz), 104.7 (d, J = 22.9 Hz), 89.8, 45.6, 37.6. 19F NMR (376
MHz, CDCl3): δ −26.6.

(E)-3-(Dimethylamino)-1-(2-hydroxy-6-methoxyphenyl)prop-2-en-1-one
(1e)
Yellow solid, 0.49 g, 76% yield. Mp: 75.7–76.9
°C. 1H NMR (400 MHz, CDCl3): δ 14.53
(s, 1H), 7.95 (d, J = 12.4 Hz, 1H), 7.24–7.19
(m, 1H), 6.55 (dd, J = 8.0, 0.8 Hz, 1H), 6.35 (dd, J = 8.4, 0.8 Hz, 1H), 6.26 (d, J = 12.4
Hz, 1H), 3.86 (s, 3H), 3.16 (s, 3H), 2.93 (s, 3H). 13C
{1H} NMR (100 MHz, CDCl3): δ 190.8, 164.8,
160.2, 154.9, 133.3, 111.8, 111.1, 101.3, 97.7, 55.8, 45.4, 37.5.
HRMS-ESI (m/z): Calculated for C12H15NO3 (M + H)+: 222.1130,
Found: 222.1129.

(E)-3-(Dimethylamino)-1-(2-hydroxy-5-methoxyphenyl)prop-2-en-1-one
(1f)14
Yellow solid,
0.43 g, 68% yield. Mp: 103.1–104.1 °C. 1H NMR
(400 MHz, CDCl3): δ 13.41 (s, 1H), 7.87 (d, J = 12.4 Hz, 1H), 7.18 (d, J = 3.2 Hz,
1H), 6.99 (dd, J =8.8, 2.8 Hz, 1H), 6.87 (d, J = 8.8 Hz, 1H), 5.71 (d, J = 12.4 Hz,
1H), 3.79 (s, 3H), 3.18 (s, 3H), 2.96 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 191.2, 157.2,
155.0, 151.3, 120.7, 120.3, 118.8, 112.8, 90.1, 56.2, 45.6, 37.6.

(E)-3-(Dimethylamino)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one
(1g)14
Yellow solid,
0.55 g, 83% yield. Mp: 139.4–140.0 °C. 1H NMR
(400 MHz, CDCl3): δ 14.49 (s, 1H), 7.83 (d, J = 12.0 Hz, 1H), 7.60 (d, J = 8.8 Hz,
1H), 6.41 (d, J = 2.4 Hz, 1H), 6.37 (dd, J = 9.2, 2.8 Hz, 1H), 5.67 (d, J = 12.0
Hz, 1H), 3.81 (s, 3H), 3.16 (s, 3H), 2.94 (s, 3H). 13C
{1H} NMR (100 MHz, CDCl3): δ 190.6, 165.6,
164.3, 154.0, 129.7, 113.9, 106.4, 101.0, 89.8, 55.4, 45.3, 37.4.

(E)-3-(Dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one
(1h)
Yellow solid, 0.50 g, 90% yield. Mp: 142.5–143.5 oC. 1H NMR (400 MHz, CDCl3): δ
15.65 (s, 1H), 7.91 (d, J = 12.4 Hz, 1H), 6.25 (d, J = 12.4 Hz, 1H), 6.06 (d, J = 2.4 Hz,
1H), 5.91 (d, J = 2.4 Hz, 1H), 3.83 (s, 3H), 3.79
(s, 3H), 3.14 (s, 3H), 2.92 (s, 3H). 13C {1H}
NMR (100 MHz, CDCl3): δ 190.0, 167.9, 164.1, 161.7,
154.4, 105.4, 96.8, 94.0, 90.6, 55.7, 55.4, 45.3, 37.4. HRMS-ESI (m/z): Calculated for C13H17NO4 (M + H)+: 252.1236, Found: 252.1234.

(E)-3-(Dimethylamino)-1-(2-hydroxy-5-methylphenyl)prop-2-en-1-one
(1i)14
Yellow solid,
1.04 g, 80% yield. Mp: 136.2–137.1 °C. 1H NMR
(400 MHz, CDCl3): δ 13.72 (s, 1H), 7.87 (d, J = 12.0 Hz, 1H), 7.47 (d, J = 1.6 Hz,
1H), 7.17 (dd, J = 8.4, 2.0 Hz, 1H), 6.84 (d, J = 8.4 Hz, 1H), 5.77 (d, J = 12.0 Hz,
1H), 3.19 (s, 3H), 2.99 (s, 3H), 2.30 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 191.7, 160.9,
154.8, 135.1, 128.3, 127.0, 120.0, 118.1, 90.2, 45.5, 37.6, 20.8.

(E)-3-(Dimethylamino)-1-(2-hydroxy-4-methylphenyl)prop-2-en-1-one
(1j)14
Yellow solid,
0.80 g, 61% yield. Mp: 130.0–131.5 °C. 1H NMR
(400 MHz, CDCl3): δ 13.97 (s, 1H), 7.86 (d, J = 12.0 Hz, 1H), 7.57 (d, J = 8.0 Hz,
1H), 6.74 (s, 1H), 6.63 (dd, J = 8.0, 1.2 Hz, 1H),
5.74 (d, J = 12.0 Hz, 1H), 3.18 (s, 3H), 2.96 (s,
3H), 2.32 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 191.4, 191.3, 163.1, 154.6, 145.2, 128.3, 119.4,
118.5, 118.0, 90.1, 45.5, 37.5.

(E)-1-(5-Chloro-2-hydroxy-4-methylphenyl)-3-(dimethylamino)prop-2-en-1-one
(1k)
Yellow solid, 1.00 g, 80% yield. Mp: 180.8–181.9
°C. 1H NMR (400 MHz, CDCl3): δ 13.87
(s, 1H), 7.85 (d, J = 12.4 Hz, 1H), 7.61 (s, 1H),
6.80 (s, 1H), 5.64 (d, J = 12.4 Hz, 1H), 3.18 (s,
3H), 2.96 (s, 3H), 2.32 (s, 3H). 13C {1H} NMR
(100 MHz, CDCl3): δ 190.1, 161.5, 155.1, 142.5, 128.1,
123.2, 120.3, 119.4, 89.8, 45.6, 37.6, 20.6. HRMS-ESI (m/z): Calculated for C12H14ClNO2 (M + H)+: 240.0791, Found: 240.0789.

(E)-3-(3-(Dimethylamino)acryloyl)-4-hydroxybenzonitrile
(1l)14
Brown solid,
0.30 g, 49% yield. Mp: 174.0–174.5 °C. 1H NMR
(400 MHz, CDCl3): δ 14.81 (s, 1H), 8.00 (d, J = 2.0 Hz, 1H), 7.94 (d, J = 12.0 Hz,
1H), 7.57 (dd, J = 8.8, 1.6 Hz, 1H), 6.97 (d, J = 8.4 Hz, 1H), 5.68 (d, J = 12.0 Hz,
1H), 3.25 (s, 3H), 3.04 (s, 3H). 13C {1H} NMR
(100 MHz, CDCl3): δ 189.5, 166.8, 155.9, 136.6, 133.4,
120.7, 119.8, 119.4, 101.2, 89.3, 45.9, 37.9.

General Procedure
for the Photoredox Reaction
A mixture
of o-hydroxyaryl enaminones (1a, 95.61
mg, 0.5 mmol), ethyl bromodifluoroacetate (253.73 mg, 1.25 mmol),
Et3N (20.24 mg, 40 mol %), NaHSO3 (78.05 mg,
0.75 mmol), and Ru(bpy)3Cl2 (4.70 mg, 1 mol
%) in DMSO (6 mL) in a sealed 25 mL Schlenk tube was irradiated with
a 45 W LED light bulb at room temperature for 24 h under a N2 atmosphere. After the reaction was completed, the resulting mixture
was diluted with 30 mL of H2O and extracted with EA (3
× 10 mL). The combined organic phases were dried over anhydrous
Na2SO4 and concentrated under vacuum. The resulting
residue was purified using flash column chromatography on silica gel
with EA/PE (1/10) to afford the desired product, 2a.

Ethyl
2,2-Difluoro-2-(4-oxo-4H-chromen-3-yl)acetate
(2a)8b
White solid,
108.6 mg, 81% yield. Mp: 89.0–90.6 °C. 1H NMR
(400 MHz, CDCl3): δ 8.33–8.30 (m, 1H), 8.20
(dd, J = 8.0, 0.4 Hz, 1H), 7.78–7.71 (m, 1H),
7.53 (d, J = 8.4 Hz, 1H), 7.49–7.44 (m, 1H),
4.39 (q, J = 7.2 Hz, 2H), 1.35 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 174.7 (t, J = 3.3 Hz), 162.8 (d, J = 32.1 Hz), 156.4, 155.2 (t, J = 9.6
Hz), 134.9, 126.3, 126.0, 123.9, 119.0 (t, J = 22.4
Hz), 118.5, 111.5 (t, J = 248.9 Hz), 63.5, 14.0. 19F NMR (376 MHz, CDCl3): δ −29.5.

Ethyl 2,2-Difluoro-2-(5-fluoro-4-oxo-4H-chromen-3-yl)acetate
(2b)
Yellow solid, 93.0 mg, 65% yield. Mp: 55.4–57.4
°C. 1H NMR (400 MHz, CDCl3): δ 8.25–8.22
(m, 1H), 7.71–7.64 (m, 1H), 7.34 (dd, J =
8.4, 0.8 Hz, 1H), 7.14–7.08 (m, 1H), 4.38 (q, J = 7.2 Hz, 2H), 1.35 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 172.9
(t, J = 3.3 Hz), 162.5 (t, J = 32.0
Hz), 160.7 (d, J = 265.5 Hz), 157.2 (d, J = 3.4 Hz), 154.4 (t, J = 9.7 Hz), 153.0, 135.0
(d, J = 10.7 Hz), 120.0 (t, J =
22.7 Hz), 114.4 (d, J = 4.6 Hz), 113.2 (d, J = 20.2 Hz), 111.2 (t, J = 249.1 Hz),
63.6, 14.0. 19F NMR (376 MHz, CDCl3): δ
−29.4, −35.4. HRMS-ESI (m/z): Calculated for C13H9F3O4 (M + H)+: 287.0531, Found: 287.0531.

Ethyl 2,2-Difluoro-2-(6-fluoro-4-oxo-4H-chromen-3-yl)acetate
(2c)8b
White solid,
86.0 mg, 60% yield. Mp: 103.0–104.1 °C. 1H
NMR (400 MHz, CDCl3): δ 8.33–8.31 (m, 1H),
7.80 (dd, J = 8.0, 3.2 Hz, 1H), 7.56 (dd, J = 9.2, 4.0 Hz, 1H), 7.49–7.43 (m, 1H), 4.37 (q, J = 7.2 Hz, 2H), 1.34 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ
173.9 (t, J = 3.2 Hz), 162.6 (t, J = 32.3 Hz), 160.1 (d, J = 247.4 Hz), 155.4 (t, J = 9.6 Hz), 152.6 (d, J = 1.8 Hz), 125.1
(d, J = 7.6 Hz), 123.1 (d, J = 25.3
Hz), 120.8 (d, J = 8.2 Hz), 118.4 (t, J = 22.5 Hz), 111.3 (t, J = 249.1 Hz), 110.8 (d, J = 23.9 Hz), 63.6, 14.0. 19F NMR (376 MHz, CDCl3): δ −29.4, −35.4.

Ethyl 2,2-Difluoro-2-(7-fluoro-4-oxo-4H-chromen-3-yl)acetate
(2d)8b
White solid,
113.0 mg, 79% yield. Mp: 67.4–68.5 °C. 1H NMR
(400 MHz, CDCl3): δ 8.30–8.26 (m, 1H), 8.18
(dd, J = 8.8, 6.0 Hz, 1H), 7.22–7.14 (m, 2H),
4.36 (q, J = 7.2 Hz, 2H), 1.33 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 173.6 (t, J = 3.2 Hz), 166.1 (d, J = 255.7 Hz), 162.5 (t, J = 32.2 Hz),
157.4 (d, J = 13.3 Hz), 155.4 (t, J = 9.5 Hz), 128.5 (d, J = 10.6 Hz), 120.7, 119.1
(t, J = 22.4 Hz), 115.2 (d, J =
22.8 Hz), 111.2 (t, J = 249.2 Hz), 105.3 (d, J = 25.4 Hz), 63.5, 13.9. 19F NMR (376 MHz, CDCl3): δ −24.1, −30.2.

Ethyl 2,2-Difluoro-2-(5-methoxy-4-oxo-4H-chromen-3-yl)acetate
(2e)8b
Yellow solid,
95.6 mg, 80% yield. Mp: 89.7–91.2 °C. 1H NMR
(400 MHz, CDCl3): δ 8.14–8.11 (m, 1H), 7.62–7.58
(m, 1H), 7.06 (dd, J = 8.4, 0.8 Hz, 1H), 6.85 (d, J = 8.4 Hz, 1H), 4.38 (q, J = 7.2 Hz, 2H),
3.96 (s, 3H), 1.34 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 174.4
(t, J = 3.3 Hz), 162.7 (t, J = 32.2
Hz), 160.2, 158.4, 153.4 (t, J = 9.9 Hz), 134.9,
120.2 (t, J = 22.4 Hz), 114.5, 111.6 (t, J = 248.2 Hz), 110.2, 107.4, 63.3, 56.7, 14.0. 19F NMR (376 MHz, CDCl3): δ −30.2.

Ethyl 2,2-Difluoro-2-(6-methoxy-4-oxo-4H-chromen-3-yl)acetate
(2f)8b
White solid,
47.7 mg, 40% yield. Mp: 86.6–87.3 °C. 1H NMR
(400 MHz, CDCl3): δ 8.31–8.30 (m, 1H), 7.54
(d, J = 3.2 Hz, 1H), 7.47 (d, J =
9.2 Hz, 1H), 7.32 (dd, J = 9.2, 2.8 Hz, 1H), 4.39
(q, J = 7.2 Hz, 2H), 3.88 (s, 3H), 1.36 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100
MHz, CDCl3): δ 174.6 (t, J = 3.3
Hz), 162.8 (t, J = 32.3 Hz), 157.7, 154.9 (t, J = 9.6 Hz), 151.3, 124.9, 124.6, 119.9, 118.2 (t, J = 22.4 Hz), 111.6 (t, J = 248.7 Hz),
104.9, 63.5, 56.1, 14.0. 19F NMR (376 MHz, CDCl3): δ −29.3.

Ethyl 2,2-Difluoro-2-(6-methoxy-4-oxo-4H-chromen-3-yl)acetate
(2g)8b
White solid,
74.0 mg, 62% yield. Mp: 70.9–72.5 °C. 1H NMR
(400 MHz, CDCl3): 1H NMR (400 MHz, CDCl3) δ 8.23–8.22 (m, 1H), 8.07 (d, J = 9.2 Hz, 1H), 7.00 (dd, J = 8.8, 2.4 Hz, 1H),
6.89 (d, J = 2.4 Hz, 1H), 4.38 (q, J = 7.2 Hz, 2H), 3.90 (s, 3H), 1.34 (t, J = 7.2 Hz,
3H).13C {1H} NMR (100 MHz, CDCl3): 13C NMR (101 MHz, CDCl3) δ 173.9 (t, J = 3.3 Hz), 164.9, 162.8 (t, J = 32.3
Hz), 158.2, 154.7 (t, J = 9.7 Hz), 127.2, 118.8 (t, J = 22.2 Hz), 117.6, 115.5, 111.5 (t, J = 248.6 Hz), 100.6, 63.4, 56.1, 13.9. 19F NMR (376 MHz,
CDCl3): δ −29.4.

Ethyl 2-(5,7-Dimethoxy-4-oxo-4H-chromen-3-yl)-2,2-difluoroacetate
(2h)
White solid, 107.7 mg, 82% yield. Mp: 111.4–112.5
°C. 1H NMR (400 MHz, CDCl3): δ 8.04
(s, 1H), 6.44 (d, J = 2.4 Hz, 1H), 6.34 (d, J = 2.4 Hz, 1H), 4.33 (q, J = 7.2 Hz, 2H),
3.87 (s, 3H), 3.85 (s, 3H), 1.30 (t, J = 7.2 Hz,
3H). 13C {1H} NMR (100 MHz, CDCl3): δ 173.4 (t, J = 3.3 Hz), 164.8, 162.7 (t, J = 32.3 Hz), 161.2, 159.9, 152.8 (t, J = 10.0 Hz), 119.9 (t, J = 22.2 Hz), 111.6 (t, J = 247.9 Hz), 109.0, 96.8, 93.0, 63.2, 56.5, 55.9, 13.9. 19F NMR (376 MHz, CDCl3): δ −30.2.
HRMS-ESI (m/z): Calculated for C15H14F2NO6 (M + H)+: 329.0837, Found: 329.0831.

Ethyl 2,2-Difluoro-2-(6-methyl-4-oxo-4H-chromen-3-yl)acetate
(2i)8b
White solid,
73.4 mg, 52% yield. Mp: 37.1–38.4 °C. 1H NMR
(400 MHz, CDCl3): δ 8.30–8.29 (m, 1H), 7.97
(d, J = 1.2 Hz, 1H), 7.54 (dd, J = 8.8, 2.0 Hz, 1H), 7.41 (d, J = 8.8 Hz, 1H), 4.38
(q, J = 7.2 Hz, 2H), 2.45 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100
MHz, CDCl3): δ 174.7 (t, J = 3.2
Hz), 162.8 (t, J = 32.4 Hz), 155.1 (t, J = 9.6 Hz), 154.7, 136.5, 136.0, 125.2, 123.6, 118.7 (t, J = 22.3 Hz), 118.2, 111.5 (t, J = 248.6
Hz), 63.5, 21.1, 14.0. 19F NMR (376 MHz, CDCl3): δ −29.4.

Ethyl 2,2-Difluoro-2-(7-methyl-4-oxo-4H-chromen-3-yl)acetate
(2j)8a
White solid,
103.0 mg, 73% yield. Mp: 116.9–118.3 °C. 1H
NMR (400 MHz, CDCl3): δ 8.29–8.27 (m, 1H),
8.06 (d, J = 8.4 Hz, 1H), 7.30 (d, J = 13.2 Hz, 2H), 4.39 (q, J = 7.2 Hz, 2H), 2.51
(s, 3H), 1.35 (t, J = 7.2 Hz, 3H). 13C
{1H} NMR (100 MHz, CDCl3): δ 174.5 (t, J = 3.3 Hz), 162.8 (t, J = 32.4 Hz), 156.5,
155.0 (t, J = 9.7 Hz), 146.5, 127.7, 125.6, 121.6,
118.8 (t, J = 22.3 Hz), 118.1, 111.5 (t, J = 248.7 Hz), 63.4, 22.0, 13.9. 19F NMR (376
MHz, CDCl3): δ −29.4.

Ethyl 2-(6-Chloro-7-methyl-4-oxo-4H-chromen-3-yl)-2,2-difluoroacetate
(2k)8a
White solid,
87.4 mg, 69% yield. Mp: 117.9–118.9 °C. 1H
NMR (400 MHz, CDCl3): δ 8.27–8.25 (m, 1H),
8.10 (s, 1H), 7.41 (s, 1H), 4.37 (q, J = 7.2 Hz,
2H), 2.50 (s, 3H), 1.34 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ
173.5 (t, J = 3.2 Hz), 162.6 (t, J = 32.2 Hz), 155.2 (t, J = 9.6 Hz), 154.6, 144.4,
133.1, 125.5, 122.9, 120.3, 118.8 (t, J = 22.5 Hz),
111.3 (t, J = 249.1 Hz), 63.6, 21.0, 14.0. 19F NMR (376 MHz, CDCl3): δ −29.4.

Ethyl 2-(6-Cyano-4-oxo-4H-chromen-3-yl)-2,2-difluoroacetate
(2l)
White solid, 96.8 mg, 66% yield. Mp: 105.5–106.7
°C. 1H NMR (400 MHz, CDCl3): δ 8.52
(d, J = 2.4 Hz, 1H), 8.35 (s, 1H), 7.97 (dd, J = 8.8, 2.0 Hz, 1H), 7.67 (d, J = 8.8
Hz, 1H), 4.40 (q, J =6.8 Hz, 2H), 1.36 (t, J = 7.2 Hz, 3H). 13C {1H} NMR (100
MHz, CDCl3): δ 172.8 (t, J = 3.2
Hz), 162.2 (t, J = 32.0 Hz), 158.0, 155.6 (t, J = 9.7 Hz), 137.1, 131.4, 124.3, 120.3, 119.9 (t, J = 22.9 Hz), 117.1, 110.7, 111.0 (t, J = 250.0 Hz), 63.7, 13.9. 19F NMR (376 MHz, CDCl3) δ: −29.7. HRMS-ESI (m/z): Calculated for C15H14F2NO6 (M + H)+: 294.0587, Found: 294.0585.

Supporting Information Available
The Supporting
Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b00383.NMR spectra of
substrates and products (Figures S1–S63)
(PDF)



Supplementary Material
ao7b00383_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
The authors
acknowledge the financial support provided by
the National Natural Science Foundation of China. We thank the Instrumental
Analysis Center of Shanghai Jiao Tong University for microanalysis.
==== Refs
References
a O’Hagan D. 
Chem. Soc. Rev. 
2008 , 37 , 308 –319 . 10.1039/B711844A .18197347  b Gouverneur V. ; Seppelt K. 
Chem. Rev. 
2015 , 115 , 563 –565 . 10.1021/cr500686k .25627818  c Gillis E. P. ; Eastman K. J. ; Hill M. D. ; Donnelly D. J. ; Meanwell N. A. 
J. Med. Chem. 
2015 , 58 , 8315 –8359 . 10.1021/acs.jmedchem.5b00258 .26200936 
a Purser S. ; Moore P. R. ; Swallow S. ; Gouverneur V. 
Chem. Soc. Rev. 
2008 , 37 , 320 –330 . 10.1039/B610213C .18197348  b Hu J. ; Zhang W. ; Wang F. 
Chem. Commun. 
2009 , 7465 –7478 . 10.1039/b916463d . c Wang J. ; Sánchez-Roselló M. ; Aceña J. L. ; del Pozo C. ; Sorochinsky A. E. ; Fustero S. ; Soloshonok V. A. ; Liu H. 
Chem.
Rev. 
2014 , 114 , 2432 –2506 . 10.1021/cr4002879 .24299176  d Li Z. ; Cui Z. ; Liu Z.-Q. 
Org. Lett. 
2013 , 15 , 406 –409 . 10.1021/ol3034059 .23305217  e Fujiwara Y. ; Dixon J. A. ; Rodriguez R. A. ; Baxter R. D. ; Dixon D. D. ; Collins M. R. ; Blackmond D. G. ; Baran P. S. 
J. Am. Chem. Soc. 
2012 , 134 , 1494 –1497 . 10.1021/ja211422g .22229949  f Jiang X.-L. ; Chen Z.-H. ; Xu X.-H. ; Qing F.-L. 
Org. Chem. Front. 
2014 , 1 , 774 –776 . 10.1039/C4QO00153B . g Matheis C. ; Jouvin K. ; Goossen L. J. 
Org. Lett. 
2014 , 16 , 5984 –5987 . 10.1021/ol5030037 .25380504 
a Ashwood M. S. ; Cottrell I. F. ; Cowden C. J. ; Wallace D. J. ; Davies A. J. ; Kennedy D. J. ; Dolling U. H. 
Tetrahedron Lett. 
2002 , 43 , 9271 –9273 . 10.1016/S0040-4039(02)02276-1 . b Zhu J. ; Zhang W. ; Zhang L. ; Liu J. ; Zheng J. ; Hu J. 
J. Org. Chem. 
2010 , 75 , 5505 –5512 . 10.1021/jo1005262 .20704426 
Gu Y. ; Chang D. ; Leng X. ; Gu Y. ; Shen Q. 
Organometallics 
2015 , 34 , 3065 –3071 . 10.1021/acs.organomet.5b00350 .
Prakash G. K. S. ; Ganesh S. K. ; Jones J.-P. ; Kulkarni A. ; Masood K. ; Swabeck J. K. ; Olah G. A. 
Angew. Chem.,
Int. Ed. 
2012 , 51 , 12090 –12094 . 10.1002/anie.201205850 .
a Ge S. ; Arlow S. I. ; Mormino M. G. ; Hartwig J. F. 
J. Am. Chem. Soc. 
2014 , 136 , 14401 –14404 . 10.1021/ja508590k .25254966  b Fujikawa K. ; Fujioka Y. ; Kobayashi A. ; Amii H. 
Org.
Lett. 
2011 , 13 , 5560 –5563 . 10.1021/ol202289z .21955064  c Feng Z. ; Chen F. ; Zhang X. 
Org. Lett. 
2012 , 14 , 1938 –1941 . 10.1021/ol3006425 .22432425  d Belhomme M. C. ; Bayle A. ; Poisson T. ; Pannecoucke X. 
Eur. J. Org. Chem. 
2015 , 2015 , 1719 –1726 . 10.1002/ejoc.201403656 .
a Akram M. O. ; Bera S. ; Patil N. T. 
Chem. Commun. 
2016 , 52 , 12306 –12309 . 10.1039/C6CC07119H . b Gaspar A. ; Matos M. J. ; Garrido J. ; Uriarte E. ; Borges F. 
Chem. Rev. 
2014 , 114 , 4960 –4992 . 10.1021/cr400265z .24555663  c Keri R. S. ; Budagumpi S. ; Pai R. K. ; Balakrishna R. G. 
Eur. J. Med. Chem. 
2014 , 78 , 340 –374 . 10.1016/j.ejmech.2014.03.047 .24691058  d Vasselin D. A. ; Westwell A. D. ; Matthews C. S. ; Bradshaw T. D. ; Stevens M. F. G. 
J. Med. Chem. 
2006 , 49 , 3973 –3981 . 10.1021/jm060359j .16789754  e Plaskon A.
S. ; Grygorenko O. O. ; Ryabukhin S. V. 
Tetrahedron 
2012 , 68 , 2743 –2757 . 10.1016/j.tet.2012.01.077 .
a Han X. ; Yue Z. ; Zhang X. ; He Q. ; Yang C. 
J.
Org. Chem. 
2013 , 78 , 4850 –4856 . 10.1021/jo400412k .23594098  b Xiang H. ; Zhao Q. ; Tang Z. ; Xiao J. ; Xia P. ; Wang C. ; Yang C. ; Chen X. ; Yang H. 
Org. Lett. 
2017 , 19 , 146 –149 . 10.1021/acs.orglett.6b03441 .27936762 
a Ravelli D. ; Protti S. ; Fagnoni M. 
Chem. Rev. 
2016 , 116 , 9850 –9913 . 10.1021/acs.chemrev.5b00662 .27070820  b Skubi K. L. ; Blum T. R. ; Yoon T. P. 
Chem. Rev. 
2016 , 116 , 10035 –10074 . 10.1021/acs.chemrev.6b00018 .27109441  c Lang X. ; Zhao J. ; Chen X. 
Chem. Soc. Rev. 
2016 , 45 , 3026 –3038 . 10.1039/C5CS00659G .27094803  d Kärkäs M. D. ; Porco J. A. ; Stephenson C. R. J. 
Chem. Rev. 
2016 , 116 , 9683 –9747 . 10.1021/acs.chemrev.5b00760 .27120289  e Chen J.-R. ; Hu X.-Q. ; Lu L.-Q. ; Xiao W.-J. 
Acc. Chem. Res. 
2016 , 49 , 1911 –1923 . 10.1021/acs.accounts.6b00254 .27551740  f Chen J.-R. ; Hu X.-Q. ; Lu L.-Q. ; Xiao W.-J. 
Chem. Soc. Rev. 
2016 , 45 , 2044 –2056 . 10.1039/C5CS00655D .26839142 
a Douglas J. J. ; Albright H. ; Sevrin M. J. ; Cole K. P. ; Stephenson C. R. J. 
Angew. Chem., Int. Ed. 
2015 , 54 , 14898 –14902 . 10.1002/anie.201507369 . b Lin Q.-Y. ; Ran Y. ; Xu X.-H. ; Qing F.-L. 
Org. Lett. 
2016 , 18 , 2419 –2422 . 10.1021/acs.orglett.6b00935 .27136958  c Koike T. ; Akita M. 
Acc. Chem. Res. 
2016 , 49 , 1937 –1945 . 10.1021/acs.accounts.6b00268 .27564676  d Rong J. ; Deng L. ; Tan P. ; Ni C. ; Gu Y. ; Hu J. 
Angew. Chem., Int. Ed. 
2016 , 55 , 2743 –2747 . 10.1002/anie.201510533 . e Fu W. ; Han X. ; Zhu M. ; Xu C. ; Wang Z. ; Ji B. ; Hao X.-Q. ; Song M.-P. 
Chem. Commun. 
2016 , 52 , 13413 –13416 . 10.1039/C6CC07771D .
Hu B. ; Chen H. ; Liu Y. ; Dong W. ; Ren K. ; Xie X. ; Xu H. ; Zhang Z. 
Chem. Commun. 
2014 , 50 , 13547 –13550 . 10.1039/C4CC05590J .
Nibbs A. E. ; Baize A.-L. ; Herter R. M. ; Scheidt K. A. 
Org. Lett. 
2009 , 11 , 4010 –4013 . 10.1021/ol901676f .19658430 
Xu R. ; Wan J.-P. ; Mao H. ; Pan Y. 
J. Am. Chem. Soc. 
2010 , 132 , 15531 –15533 . 10.1021/ja107758d .20958071 
Akram M. O. ; Bera S. ; Patil N. T. 
Chem. Commun. 
2016 , 52 , 12306 –12309 . 10.1039/C6CC07119H .

